Group 6 Copy 535
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Mapping Addiction

    Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

    Will This Mobile Resource Help Healthcare Professionals Prescribe Antidepressants?

    Understanding pharmacological agents is key to treatment selection. For the increasing involvement of primary...

    Backer Badge Funded